Juvenile idiopathic arthritis

A Martini, DJ Lovell, S Albani, HI Brunner… - Nature Reviews …, 2022 - nature.com
Juvenile idiopathic arthritis (JIA) is an umbrella term for arthritis of unknown origin, lasting
for> 6 weeks with onset before 16 years of age. JIA is the most common chronic …

Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors

A Heiligenhaus, C Heinz, C Edelsten… - Ocular Immunology …, 2013 - Taylor & Francis
Juvenile idiopathic arthritis (JIA) is the most common systemic disease associated with
uveitis in childhood. The frequency of JIA-associated uveitis (JIAU) varies geographically …

The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort

J Guzman, K Oen, LB Tucker, AM Huber… - Annals of the …, 2015 - ard.bmj.com
Objective To describe clinical outcomes of juvenile idiopathic arthritis (JIA) in a prospective
inception cohort of children managed with contemporary treatments. Methods Children …

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis

F Mcerlane, MW Beresford, EM Baildam… - Annals of the …, 2013 - ard.bmj.com
Objectives To investigate the validity and feasibility of the Juvenile Arthritis Disease Activity
Score (JADAS) in the routine clinical setting for all juvenile idiopathic arthritis (JIA) disease …

Update on the epidemiology, risk factors and disease outcomes of Juvenile idiopathic arthritis

J Palman, S Shoop-Worrall, K Hyrich… - Best Practice & Research …, 2018 - Elsevier
Juvenile idiopathic arthritis (JIA) is the most common inflammatory joint condition of
childhood and represents seven JIA subtypes characterised by distinct clinical and …

Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry

T Beukelman, S Ringold, TE Davis… - The Journal of …, 2012 - jrheum.org
Objective. To characterize disease-modifying antirheumatic drug (DMARD) use for children
with juvenile idiopathic arthritis (JIA) in the United States and to determine patient factors …

A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein

H Moncrieffe, S Ursu, D Holzinger, F Patrick… - …, 2013 - academic.oup.com
Objectives. In JIA there is an unmet need for biomarkers with which to identify patients who
will respond well to MTX. The aim of this study was to define the prognostic value of baseline …

Juvenile idiopathic arthritis associated uveitis

E Carlsson, MW Beresford, AV Ramanan, AD Dick… - Children, 2021 - mdpi.com
Juvenile idiopathic arthritis (JIA) is the most common childhood rheumatic disease. The
development of associated uveitis represents a significant risk for serious complications …

The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German …

C Sengler, J Klotsche, M Niewerth, I Liedmann… - RMD open, 2015 - rmdopen.bmj.com
Objective To describe the disease characteristics of patients with juvenile idiopathic arthritis
(JIA) included in an inception cohort, to analyse how many patients from each JIA category …

Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with juvenile idiopathic arthritis …

F McErlane, HE Foster, R Carrasco, EM Baildam… - …, 2016 - academic.oup.com
Objectives. The medical management of JIA has advanced significantly over the past 10
years. It is not known whether these changes have impacted on outcomes. The aim of this …